Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review.
Adjuvants, Immunologic
/ therapeutic use
Alginates
/ therapeutic use
Animals
COVID-19
/ immunology
COVID-19 Vaccines
/ therapeutic use
Chitosan
/ therapeutic use
Drug Delivery Systems
Humans
Hyaluronic Acid
/ therapeutic use
Plant Gums
/ therapeutic use
SARS-CoV-2
/ immunology
beta-Glucans
/ therapeutic use
Alginate
Chitosan
Gums
Hyaluronic acid
Vaccines
β-Glucan
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
01 Jul 2021
01 Jul 2021
Historique:
received:
21
03
2021
revised:
19
05
2021
accepted:
23
05
2021
pubmed:
29
5
2021
medline:
13
7
2021
entrez:
28
5
2021
Statut:
ppublish
Résumé
Pathogen transmission is a widespread threat to global human health. Vaccines are very important during the outbreak of a pandemic. Destructive fractures caused by a sudden outbreak of COVID-19 have spurred vaccine production at an unprecedented rate. The strategy of an effective vaccine delivery system is opening up novel probabilities to make more immunization. Indeed, vaccination is the most successful way to prevent deaths from infectious diseases. In order to optimal immune response production or improvement in the effectiveness of vaccines, delivery systems or adjuvants are required. Natural polymers such as chitosan, alginate, hyaluronic acid, gums, and β-glucan with antiviral activity have good potential as adjuvant or delivery systems for vaccine formulation development and design vaccine delivery devices. According to the antiviral performance and immunomodulation of these biopolymers, they will play significant characters in the anti-COVID-19 field. In this mini-review, the recent progress in vaccine development by using biopolymers is presented which, provides a reference for their research on anti-COVID-19 drugs and vaccines.
Identifiants
pubmed: 34048834
pii: S0141-8130(21)01130-2
doi: 10.1016/j.ijbiomac.2021.05.155
pmc: PMC8146404
pii:
doi:
Substances chimiques
Adjuvants, Immunologic
0
Alginates
0
COVID-19 Vaccines
0
Plant Gums
0
beta-Glucans
0
Hyaluronic Acid
9004-61-9
Chitosan
9012-76-4
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1931-1940Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
Front Bioeng Biotechnol. 2020 Nov 13;8:558349
pubmed: 33282847
ACS Nano. 2020 Oct 27;14(10):12370-12389
pubmed: 33001626
Evid Based Complement Alternat Med. 2016;2016:7659684
pubmed: 27493674
Int J Biol Macromol. 2021 Apr 1;175:330-340
pubmed: 33556403
Turk J Biol. 2020 Oct 13;44(5):304-314
pubmed: 33110368
Biologicals. 2018 Jan;51:46-53
pubmed: 29126666
Macromol Biosci. 2021 Apr;21(4):e2000375
pubmed: 33624916
Pharmaceutics. 2019 Feb 09;11(2):
pubmed: 30744102
Int J Biol Macromol. 2020 Dec 1;164:331-343
pubmed: 32679328
Int J Biol Macromol. 2021 Apr 15;176:567-577
pubmed: 33581203
ACS Appl Mater Interfaces. 2020 Nov 25;12(47):52285-52297
pubmed: 33179910
Acta Biomater. 2018 Sep 15;78:211-223
pubmed: 30098441
Adv Healthc Mater. 2019 Jan;8(2):e1800953
pubmed: 30549426
Carbohydr Polym. 2020 Feb 1;229:115423
pubmed: 31826462
Asian J Pharm Sci. 2019 Mar;14(2):216-221
pubmed: 32104453
Int J Biol Macromol. 2020 Feb 1;144:978-994
pubmed: 31669465
Biomed Res Int. 2017;2017:3925024
pubmed: 28555192
Biomaterials. 2021 Jan;268:120597
pubmed: 33360074
Microb Pathog. 2018 Feb;115:74-85
pubmed: 29223454
Int J Biol Macromol. 2020 Jun 1;152:904-912
pubmed: 32114177
Int J Biol Macromol. 2021 May 15;179:33-44
pubmed: 33607132
Int J Biol Macromol. 2019 Feb 1;122:930-939
pubmed: 30412757
Bioconjug Chem. 2019 Dec 18;30(12):3028-3037
pubmed: 31738536
Bioresour Technol Rep. 2021 Feb;13:100623
pubmed: 33521606
Vaccine. 2020 Jan 29;38(5):1096-1104
pubmed: 31813649
Clin Exp Immunol. 2019 Nov;198(2):143-152
pubmed: 31400225
RSC Adv. 2018 Apr 11;8(24):13612-13624
pubmed: 35542506
Int J Biol Macromol. 2020 Jul 1;154:466-476
pubmed: 32194106
Eur J Pharm Sci. 2007 Dec;32(4-5):278-90
pubmed: 17884394
Vaccine. 2010 Dec 16;29(2):314-22
pubmed: 21034826
Niger J Physiol Sci. 2020 Dec 31;35(2):167-171
pubmed: 34009205
Mol Pharm. 2019 May 6;16(5):1971-1981
pubmed: 30964694
Int J Pharm. 2018 Jan 15;535(1-2):261-271
pubmed: 29133207
Clin Nutr ESPEN. 2021 Apr;42:148-152
pubmed: 33745569
Eur J Pharm Biopharm. 2018 Oct;131:33-43
pubmed: 30048745
J Immunoassay Immunochem. 2020 May 3;41(3):311-321
pubmed: 32119592
Mol Pharm. 2019 Mar 4;16(3):1105-1118
pubmed: 30715891
Clin Exp Pharmacol Physiol. 2020 Nov;47(11):1874-1878
pubmed: 32881059
AAPS J. 2010 Dec;12(4):519-24
pubmed: 20577912
Pharmaceutics. 2020 Oct 14;12(10):
pubmed: 33066594
BMC Vet Res. 2018 Dec 22;14(1):415
pubmed: 30577861
J Control Release. 2018 Sep 28;286:460-466
pubmed: 30102940